CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients (CORTERAS)
Inflammatory Response, Weakness, Muscle
About this trial
This is an interventional treatment trial for Inflammatory Response
Eligibility Criteria
Inclusion Criteria:
- Aged 60 years or older.
Scheduled for one of the predefined surgical procedures:
- off-pump coronary bypass surgery
- on-pump coronary bypass surgery
- aortic valve replacement
- laparoscopic hemicolectomies
- thoracoscopic lung resections
- femoral popliteal and tibial bypass surgery
- laparoscopic radical prostatectomies
Exclusion Criteria:
- Lack of informed consent or inability to give informed consent.
- Severe postoperative nausea & vomiting (PONV), needing corticosteroids as PONV prophylaxis.
- Urgent, not elective surgery
- Hypersensitivity or known allergic reactions to methylprednisolone
Preoperative systemic use of steroids:
- Including, but not limited to, the use of corticosteroids > 4 weeks before surgery of at least 4 mg methylprednisolone equivalents.
- Excluding inhalational and topical steroids
- Preexisting muscle disease o Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.
Sites / Locations
- Ziekenhuis Oost-LimburgRecruiting
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
Placebo
Methylprednisolone
100 ml of NaCl 0,9%, not containing corticosteroids, given at induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 100 ml of NaCl 0,9% will be administered at the beginning of CPB.
250 mg of methylprednisolone made up with 100 ml NaCl 0,9%, given at the induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 250 mg methylprednisolone will be administered at the beginning of CPB.